Overview of generalized anxiety disorder in the elderly

Journal of Clinical Psychiatry

Volumn 57, Issue SUPPL. 7, 1996, Pages 34-45

  Schneider, Lon S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AMNESIA; ANXIETY NEUROSIS; DEPRESSION; DISEASE SEVERITY; HUMAN; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REVIEW;

ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; AGED; ANTI-ANXIETY AGENTS; ANTIPSYCHOTIC AGENTS; ANXIETY DISORDERS; BARBITURATES; BENZODIAZEPINES; BUSPIRONE; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PHARMACOEPIDEMIOLOGY;

EID: 0029738081     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Regier DA, Boyd JH, Burke JD, et al. One month prevalence of mental disorders in the United States. Arch Gen Psychiatry 1988;45:977-986
2. Bland RC, Newman SG, Orn H. Prevalence of psychiatric disorders in the elderly in Edmonton. Acta Psychiatr Scand Suppl 1988;77(suppl 338):57-63
3. Uhlenhuth EH, Balter MB, Mellinger GD, et al. Symptom checklist syndromes in the general population: co-relations with psychotherapeutic drug use. Arch Gen Psychiatry 1983;40:1167-1173
4. Copeland JRM, Gurland BJ, Dewey ME, et al. Is there more dementia, depression and neurosis in New York? a comparative study of the elderly in New York and London using the computer diagnosis AGECAT. Br J Psychiatry 1987;151:466-473
5. Lindesay J, Briggs K, Murphy E. The Guy's/Age Concern Survey: prevalence rates of cognitive impairment, depression and anxiety in an urban elderly community. Br J Psychiatry 1989;155:317-329
6. Flint AJ. Epidemiology and comorbidity of anxiety disorders in the elderly. Am J Psychiatry 1994;151:640-649
7. Lindesay J. Phobic disorders in the elderly. Br J Psychiatry 1991;159: 531-541
8. Parmelee PA, Katz IR, Lawton MP. Anxiety and its association with depression among institutionalized elderly. American Journal of Geriatric Psychiatry 1993;1:46-58
9. Alexopoulos GS. Anxiety-depression syndromes in old age. International Journal of Geriatric Psychiatry 1990;5:351-353
10. Ben-Arie O, Swartz L, Dickman BJ. Depression in the elderly living in the community: its presentation and features. Br J Psychiatry 1987;150: 169-174
11. Kuch K, Cox BJ. Symptoms of PTSD in 124 survivors of the Holocaust. Am J Psychiatry 1992;149:337-340
12. Kluznik JC, Speed N, Van Valkenburg C, et al. Forty-year follow-up of United States prisoners of war. Am J Psychiatry 1986;143:1443-1446
13. Rosen J, Fields RB, Hand AM, et al. Concurrent posttraumatic stress disorder in psychogeriatric patients. J Geriatr Psychiatry Neurol 1989;2: 65-69
14. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
15. Castillo CS, Starkstein SE, Fedoroff JP, et al. Generalized anxiety disorder after stroke. J Nerv Ment Dis 1993;181:100-106
16. Katon W, Vitiliano P, Anderson K, et al. Panic disorder: residual symptoms after the acute attacks abate. Compr Psychiatry 1987;28(2):151-158
17. Kushner MG, Sher KJ, Beitman BD. The relation between alcohol problems and the anxiety disorders. Am J Psychiatry 1990;147:685-695
18. Weissman MM, Klerman GL, Markovitz JS, et al. Suicidal ideation and suicide attempts in panic disorder and attacks. N Engl J Med 1989;321: 1209-1214
19. Coryell W. Mortality of anxiety disorders. In: Noyes R Jr, Roth M, Burrows GD, eds. Classification, Etiological Factors and Associated Disturbances. Amsterdam, The Netherlands: Elsevier/North Holland Science Publications; 1988:311-320
20. Jenike MA. Obsessive-compulsive disorders in the elderly. In: Jenike MA, ed. Geriatric Psychiatry and Pharmacology: A Clinical Approach. Chicago, III: Year Book Medical Publishers; 1989:339-362
21. American Psychiatric Association. APA Task Force on Benzodiazepine Dependence, Toxicity and Abuse. Washington, DC: American Psychiatric Press; 1990
22. Salzman C, Lebowitz BD, eds. Anxiety in the Elderly. New York, NY: Springer; 1991
23. Allen RM. Tranquilizers and sedative/hypnotics: appropriate use in the elderly. Geriatrics 1986;41:75-88
24. Beers M, Avom J, Soumerai SB, et al. Psychoactive medication use in intermediate-care facility residents. JAMA 1988;260:3016-3020
25. Lyndon RW, Russell JD. Benzodiazepine use in a rural general practice population. Aust N Z J Psychiatry 1988;22:293-298
26. Ray WA, Griffin MR, Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA 1989;262: 3303-3307
27. Busto U, Lanctot KL, Isaac P, et al. Benzodiazepine use and abuse in Canada. Can Med Assoc J 1989;141:917-921
28. Garrard J, Chen V, Dowd B. The impact of the 1987 federal regulations on the use of psychotropic drugs in Minnesota nursing homes. Am J Public Health 1995;85(6):771-776
29. Linden M, Gothe H. Benzodiazepines substitution in medical practice: analysis of pharmacoepidemiologic data based on expert interviews. Pharmacopsychiatry 1993;26:107-113
30. McNutt LA, Coles FB, McAuliffe T, et al. Impact of regulation on benzodiazepine prescribing to a low income elderly population, New York state. J Clin Epidemiol 1994;47:613-625
31. Pomara N, Deptula D, Singh R, et al. Cognitive toxicity of benzodiazepines in the elderly. In: Salzman C, Lebowitz BD, eds. Anxiety in the Elderly. New York, NY: Springer; 1991
32. Salzman C. Treatment of anxiety. In: Salzman C, ed. Clinical Geriatric Psychopharmacology. 2nd ed. Baltimore, Md: Williams & Wilkins; 1992:189-212
33. Schneider LS. Efficacy of treatment for geropsychiatric patients with severe mental illness. Psychopharmacol Bull 1993;29:501-524
34. Moskowitz H, Smiley A. Effects of chronically administered buspirone and diazepam on driving-related skills performance. J Clin Psychiatry 1982;43 (12, sec 2):45-55
35. Pohl R, Balon R, Yeragani VK, et al. Serotonergic anxiolytics in the treatment of panic disorder: a controlled study with buspirone. Psychopathology 1989;22(suppl 1):60-67
36. Robinson D, Napoliello MJ, Schenk J. The safety and usefulness of buspirone as an anxiolytic drug in elderly versus young patients. Clin Ther 1988;10:740-746
37. Levine S, Napoliello MJ, Domantay AG. An open study of buspirone in octogenarians with anxiety. Human Psychopharmacology 1989;4:51-53
38. Gammans RE, Westrick ML, Shea JP, et al. Pharmacokinetics of buspirone in elderly subjects. J Clin Pharmacol 1989;29:72-78
39. Böhm C, Robinson DS, Gammans RE, et al. Buspirone therapy in anxious elderly patients: a controlled clinical trial. J Clin Psychopharmacol 1990; 10(3, suppl):47S-51S
40. Hart RP, Colenda CC, Hamer RM. Effects of buspirone and alprazolam on the cognitive performance of normal elderly subjects. Am J Psychiatry 1991;148:73-77
41. Schneider LS, Sobin P. Non-neuroleptic medication in the management of agitation in Alzheimer's disease and other dementia: a selective review. International Journal of Geriatric Psychiatry 1991;6:691-708
42. Katz IR, Simpson GM, Curlik SM, et al. Pharmacologic treatment of major depression for elderly patients in residential care settings. J Clin Psychiatry 1990;51(7, suppl):41-47
43. Reynolds CF, Frank E, Perel JM, et al. Treatment of consecutive episodes of major depression in the elderly. Am J Psychiatry 1994;151:1740-1743
44. Glassman AH, Roose SP. Risks of antidepressants in the elderly: tricyclic antidepressants and arrhythmia - revising risks. Gerontology 1994;40 (suppl 1):15-20
45. Roose SP, Glassman AH, Attia E, et al. Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry 1994;151:1735-1739
46. Gerner R, Estabrook W, Steuer J, et al. Treatment of geriatric depression with trazodone, imipramine, and placebo: a double-blind study. J Clin Psychiatry 1980;41:216-220
47. Rickels K, Downing R, Schweizer E, et al. Antidepressants for the treatment of generalized anxiety disorder: a placebo-controlled comparison of imipramine, trazodone, and diazepam. Arch Gen Psychiatry 1993;50:884-895
48. Georgotas A, McCue RE, Hapworth W, et al. Comparative efficacy and Safety of MAOIs vs TCAs in treating depression in the elderly. Biol Psychiatry 1986;21:1155-1166
49. Sheehan DV, Ballenger J, Jacobsen G. Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms. Arch Gen Psychiatry 1980;37:51-59
50. Zitrin CM, Klein DF, Woerner MG, et al. Treatment of phobias, I: comparison of imipramine hydrochloride and placebo. Arch Gen Psychiatry 1983; 40:125-138
51. Schneier FR, Liebowitz MR, Davies SO, et al. Fluoxetine in panic disorder. J Clin Psychopharmacol 1990;10:119-121
52. Liebowitz MR, Schneier F, Campeas R, et al. Phenelzine vs atenolol in social phobia: a placebo-controlled comparison. Arch Gen Psychiatry 1992; 49:290-300
53. Van Vliet IM, den Boer JA, Westenberg HGM. Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor. Eur Neuropsychopharmacol 1992; 2:21-29
54. Schneier FR, Saoud JB, Campeas R, et al. Buspirone in social phobia. J Clin Psychopharmacol 1993;13:251-256
55. Jenike MA, Baer L. An open trial of buspirone in obsessive-compulsive disorder. Am J Psychiatry 1988;145:1285-1286
56. Jenike MA, Baer L, Buttolph L. Buspirone augmentation of fluoxetine in patients with obsessive compulsive disorder. J Clin Psychiatry 1991;52: 13-14